about
The Long Path of Human Placenta, and Its Derivatives, in Regenerative MedicineIn vivo tracking of human placenta derived mesenchymal stem cells in nude mice via ¹⁴C-TdR labelingRegulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment.Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues.Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study.Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls.Internalization of nanopolymeric tracers does not alter characteristics of placental cells.Soluble factors of amnion-derived cells in treatment of inflammatory and fibrotic pathologies.The dichotomy of placenta-derived cells in cancer growth.Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype.Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells.Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets.Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2.Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.A novel activation-induced cytidine deaminase gene mutation in a Tunisian family with hyper IgM syndrome.Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage features.Protection of Brain Injury by Amniotic Mesenchymal Stromal Cell-Secreted Metabolites.Isolation, Culture, and Phenotypic Characterization of Mesenchymal Stromal Cells from the Amniotic Membrane of the Human Term Placenta.Mutational Analysis of Human BAFF Receptor TNFRSF13C (BAFF-R) in Patients with Common Variable ImmunodeficiencyAutophagy: a potential key contributor to the therapeutic action of mesenchymal stem cellsPerinatal Mesenchymal Stromal Cells and Their Possible Contribution to Fetal-Maternal ToleranceStrontium Promotes the Proliferation and Osteogenic Differentiation of Human Placental Decidual Basalis- and Bone Marrow-Derived MSCs in a Dose-Dependent MannerMesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine
P50
Q26779265-BF20049C-DCE0-44CE-A4ED-0857BE699504Q35662562-C70E0232-13A5-4E38-8CC6-6B871DCDADEEQ35823514-774D65A5-40B8-4A2C-98F1-9D296E114664Q35825031-2DCE1801-AE31-438E-9EA0-6A9CD9096EB4Q36004194-A6B6DAFB-66C4-4231-8DD2-CFD38F9FDC68Q36476871-EC56D42D-A072-443F-9820-D328C84142D0Q36942333-ADE1DBC9-2834-4085-B3A8-7B511C4659DCQ38070020-11F9BC24-4E72-4A26-AB96-D12A646E213FQ39330852-79DECF32-FBD3-4565-9483-1A4EB0C55B1DQ39750500-8127EBB4-B150-4342-A34B-D9009AB48DE3Q39910521-94E0A0E9-7EBA-4130-A31C-C4FE47CEBEDBQ41518676-4C33C97C-014F-40A6-884B-0AA2C95BB772Q41535597-A2432D89-0BDC-4113-A277-63D2E51BFF84Q42835129-9D2FE2E9-542A-4147-A116-3C15BF64FDCCQ45062321-2F15A8DA-EA3A-4AAD-A70E-D44AF64C1D5BQ47107647-D58ADA8E-5F42-4F17-B926-7E07E8F8B5EAQ48475882-EB538C8F-4494-4582-B291-CD8ED8097133Q53092675-7AABC8C7-FC33-4E14-A741-642BA5A80B24Q57394760-14ACB05B-D597-43A1-AFAA-5E73B8A39BFBQ64763399-2A9536F5-EAE5-459F-A572-F99768BEC079Q91190347-36F02A6D-BF73-4D52-BBF0-E2060205FAE8Q92307965-4CEC327A-4CB4-486B-847E-E76E8EB28670Q92630103-557983B5-2E0E-4EEA-A9B1-50FCE42B4081
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonietta Silini
@ast
Antonietta Silini
@en
Antonietta Silini
@es
Antonietta Silini
@nl
type
label
Antonietta Silini
@ast
Antonietta Silini
@en
Antonietta Silini
@es
Antonietta Silini
@nl
prefLabel
Antonietta Silini
@ast
Antonietta Silini
@en
Antonietta Silini
@es
Antonietta Silini
@nl
P106
P1153
8891225600
P31
P496
0000-0001-6208-3583